ReviewJournal of liver cancer2026

Strategic drug sequencing in hepatocellular carcinoma in the era of chemo-diversity: maximizing the therapeutic benefit of lenvatinib.

Hideki Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.